Hybrid systems in Medical Imaging
|
|
- Roderick Oswin Malone
- 5 years ago
- Views:
Transcription
1 Hybrid systems in Medical Imaging from PET/CT to PET/MR Osman Ratib, MD, PhD, FAHA Professor and chair Department of Medical Imaging and Information Sciences Head of division of Nuclear Medicine University Hospital of Geneva
2 History of hybrid imaging Origin of PET / CT University of Pittsburgh Medical Center
3 History of hybrid imaging Sequential PET-CT
4 FDG uptake in Tumors Universal tracer? SUV Melanoma HG NHL HD Colorectal CA NSCLC Esophageal CA Head/Neck HG sarcoma Infiltrating ductal CA Poorly diff - thyroid Testicular CA Pancreas Recurrent ovarian CA LG NHL Bronchoalveolar CA Cervical CA Renal cell CA Lobular CA Mucinous CA Prostate CA Primary ovarian CA Well diff - thyroid Hot Medium Hot Not So Hot 2009 Hôpitaux Universitaires de Genève
5 New tracers in PET imaging C11 - ACETATE Applications: - Hepatocellular cancers - Renal cancers - Prostate cancers 2009 Hôpitaux Universitaires de Genève
6 New tracers in PET imaging F18 - Tyrosine (FET) MRI PET-CT Applications: - Glyomas and brain cancers 2009 Hôpitaux Universitaires de Genève
7 New tracers in PET imaging 18 F - Choline Applications: 2009 Hôpitaux Universitaires de Genève - Prostate cancers (recurrence)
8 New tracers in PET imaging 18 F - Dopamine 18 F-FDG 18 F-DOPA Applications: - Endocrine tumors - Carcinoïd tumors 2008 Hôpitaux Universitaires de Genève
9 New tracers in PET imaging 18 F PET 2009 Hôpitaux Universitaires de Genève
10 New tracers in PET imaging 18 F - NaF PET Planar SPECT 18 F NaF - PET 2009 Hôpitaux Universitaires de Genève
11 FDG PET impact on patient management 2011 Hôpitaux Universitaires de Genève 11
12 FDG PET: Impact on patient management Staging Reference No.pts Change in mgmt Delbeke et al, J Nucl Med 2000; 41: 275P 27 31% Yap et al, J Nucl Med 2000; 41: % Dittman et al, J Nucl Med 2000; 41: 71P 24 8% Seltzer et al, J Nucl Med 2000; 41: 108P % Kostakoglu et al, J Nucl Med 2000; 41: 118P 62 5% Shah et al, Br J Radiology 2000; 73: % Jerusalem et al, NM Commun 1999; 20: % Moog et al, Radiology 1998; 206: % Bangerter et al, Ann Oncol 1998; 9: % Hoh et al, J Nucl Med 1997; 38: % Moog et al, Radiology 1997; 203: % Total: % Recurrence Spaepen et al, J Nucl Med 2000; 41: % Kostakoglu et al, J Nucl Med 2000; 41: 118P 62 5% Total: % 2011 Hôpitaux Universitaires de Genève 12
13 PET in oncology Impact of PET imaging on clinical management Changes in clinical staging (n = 583) Lung Cancer (n = 285) Non-Lung (n = 298) Up Down No Change No Answer Seltzer et al, UCLA School of Medicine 2011 Hôpitaux Universitaires de Genève
14 PET in oncology Impact of PET imaging on clinical management Changes in treatment (n = 583) Lung Cancer (n = 285) Non-Lung (n = 298) 30 % Major Minor No Change No Answer Seltzer et al, UCLA School of Medicine 2011 Hôpitaux Universitaires de Genève
15 FDG PET vs PET-CT in Oncology 2008 Hôpitaux Universitaires de Genève
16 PET/CT in oncology Advent of hybrid imaging Currently available data indicate that PET/CT is more sensitive and specific than either of its constituent imaging methods alone and probably more so than images obtained separately from PET and CT and viewed side by side. Published results on the use of PET/CT in oncology are still limited, but several well-designed studies have demonstrated the benefits of PET/CT, especially in staging of non small cell lung cancer, recurrent colorectal cancer, and malignant lymphoma 2008 Hôpitaux Universitaires de Genève
17 PET/CT in oncology Advent of hybrid imaging 2008 Hôpitaux Universitaires de Genève
18 2008 Hôpitaux Universitaires de Genève PET/CT in oncology
19 Hybrid imaging From PET-CT to PET-MR CT PET MRI CT PET-CT PET PET-MRI MRI PET-CT PET-MRI
20 PET-MRI developements Pioneer work by S. Cherry
21 PET-MRI developments First animal prototype S. Cherry
22 Hybrid imaging Whole body PET-MR PET PET-MRI MRI
23 PET-MRI developments Sequential vs simultaneous acquisition Head Insert Whole body sequential Eur J Nucl Med Mol Imaging (2009) 36 (Suppl 1):S86 S92 DOI /s Whole body simultaneous
24 PET-MRI hybrid imaging Whole-body PET-MRI 3m MRI PET
25 First whole-body PET-MRI prototype Two first luminary sites Mount Sinai Medical Center (New York) Pr. Z.Fayad a u r b Fe ry 2 Geneva University Hospital (Geneva) Pr. O.Ratib
26 Whole-body PET-MRI MR-based attenuation correction Uncorrected DIXON in phase DIXON fat DIXON water Attenuation map Corrected Bed and surface coils attenuation maps Spine 15ch Cardiac 32ch posterior Breast 7ch Head 8ch NV 16ch +
27 Whole-body PET-MRI Clinical workflow Whole body MRI (AC and localization) 2. Whole body PET 3 3. Additional diagnostic MR images
28 PET-MRI in Geneva Alpha & beta phase 62 patients had a PET-CT followed by a PET-MR Average time between studies was 85 ± 22 minutes ranging from 49 minutes to 120 minutes Most patients had a complementary diagnostic MRI Images were interpreted by a team of radiologists and nuclear medicine physicians PET Image quality was graded and compared between PET-CT and PET-MR SUV were measured and compared on both PET studies
29 PET-MRI in Geneva Alpha & beta phase PET-CT & PET-MR workflow CT PET 1 CT MR PET 2 MR FDG Iodine Gadolinium PET-CT PET-MR
30 PET-MRI in Geneva Resullts No significant difference in image quality and identification of abnormal lesions were found between the two PET scans of each case Images performed on the PET-MR were comparable to those acquired on the PET-CT scanner and often showed higher contrast with less background noise due to a well known FDG redistribution No significant artifacts from attenuation correction or from interference between the two scanners were observed Whole-body MRI sequence were often suboptimal for accurate anatomical localization and additional high resolution images of selected anatomical regions were used
31 PET-MRI in Geneva Resullts SUV measurements performed on two sequential PET studies (separated by 85 ± 22 minutes) showed a significant variation in biodistribution in different organs, but showed comparable results in tumor lesions PET-CT PET-MR
32 PET-MRI in Geneva Resullts SUV measurements performed on two sequential PET studies (separated by 85 ± 22 minutes) showed a significant variation in biodistribution in different organs, but showed comparable results in tumor lesions
33 PET-MRI in Geneva Resullts SUV measurements performed on two sequential PET studies (separated by 85 ± 22 minutes) showed a significant variation in biodistribution in different organs, but showed comparable results in tumor lesions
34 Clinical Studies
35 PET-MRI in clinical routine Potential clinical applications Pediatric oncology and epilepsy workup Oncology investigation that require already a diagnostic MRI in addition to PET-CT: Head & Neck cancer (pre and post-op) Prostate cancers Breast imaging New emerging clinical applications: Cardiac imaging (viability, ischemia?) Gynecological cancers Bone metastases (F 18 -NaF)
36 PET-MR in Geneva Research team Steering committee Osman Ratib Christophe Becker Magalie Vialon Habib Zaidi Jean-Paul Vallée Maria Isabel Vargas Michael Wissmeyer François Riondel Béatrice Paridant Michel Velazquez Jean-Noel Hyacinthe Team (1) Oncology H&N: Minerva Becker Michael Wissmeyer + Olivier Rager Magalie Vialon Team (2) Oncology prostate: Jean Paul Vallée Charles Steiner + Valentina Garibotto Jean-Noel Hyacinthe Team (3) Oncology breast: Pierre Loubeyre Olivier Rager + Jean-Pierre Willi Jean-Noel Hyacinthe Philips support and R&D team Jeffrey Kaste Troy Havens Piotr Maniawski Susanne Heinzer Antonis Kalemis Navdeep Ojha Zhiqiang Hu Kevin Kilroy Michelle Granny Dominique Joliat
37 PET-MR in Geneva Research team Steering committee Osman Ratib Christophe Becker Magalie Vialon Habib Zaidi Jean-Paul Vallée Maria Isabel Vargas Michael Wissmeyer François Riondel Béatrice Paridant Michel Velazquez Jean-Noel Hyacinthe Team (1) Oncology H&N: Minerva Becker Michael Wissmeyer + Olivier Rager Magalie Vialon Team (2) Oncology prostate: Jean Paul Vallée Charles Steiner + Valentina Garibotto Jean-Noel Hyacinthe Team (3) Oncology breast: Pierre Loubeyre Olivier Rager + Jean-Pierre Willi Jean-Noel Hyacinthe Philips support and R&D team Jeffrey Kaste Troy Havens Piotr Maniawski Navdeep Ojha Zhiqiang Hu Kevin Kilroy Michelle Granny Laurent Renevey Sylvain Sans Dominique Joliat
MRI-PET: Oncologic Applications
MRI-PET: Oncologic Applications Pablo R. Ros, MD University Hospitals Case Medical Center Case Western Reserve University SCBT-MR Boston, MA October, 2012 Pablo.Ros@UHhospitals.org Acknowledgement Osman
More informationMolecular Imaging in the Development of Cancer Therapeutics. Johannes Czernin
Molecular Imaging in the Development of Cancer Therapeutics Johannes Czernin Ahmanson Biological Imaging Division University of California Los Angeles Cancer Statistics Cancer Type 5-year Survival Rate
More informationNuclear medicine in oncology. 1. Diagnosis 2. Therapy
Nuclear medicine in oncology 1. Diagnosis 2. Therapy Diagnosis - Conventional methods - Nonspecific radiopharmaceuticals cumulating in tumours - Specific radiopharmaceuticals (receptor- and immunoscintigraphy)
More informationIndex. Surg Oncol Clin N Am 16 (2007) Note: Page numbers of article titles are in boldface type.
Surg Oncol Clin N Am 16 (2007) 465 469 Index Note: Page numbers of article titles are in boldface type. A Adjuvant therapy, preoperative for gastric cancer, staging and, 339 B Breast cancer, metabolic
More informationValue of true whole-body FDG- PET/CT scanning protocol in oncology and optimization of its use based on primary malignancy
Value of true whole-body FDG- PET/CT scanning protocol in oncology and optimization of its use based on primary malignancy Ronnie Sebro MD, Ph.D Carina Mari Aparici MD, Miguel Hernandez Pampaloni MD, PhD
More informationPET/MR:Techniques, Indications and Applications
PET/MR:Techniques, Indications and Applications Franz Wolfgang Hirsch Professor and Head of the Department of Pediatric Radiology University Hospital Leipzig / Germany Children s Hospital University Leipzig
More informationPET/MRI: a new era in multimodality molecular imaging
Clin Transl Imaging (2013) 1:5 10 DOI 10.1007/s40336-013-0003-5 REVIEW ARTICLE PET/MRI: a new era in multimodality molecular imaging Osman Ratib Received: 22 October 2012 / Accepted: 10 January 2013 /
More informationNuclear Medicine in Oncology
Radiopharmaceuticals Nuclear Medicine in Oncology Practice Pharmaceutical Radionuc lide Function Tumor type Diphosphonates Tc-99m Osteoblast Bone tumor & metast. Ga-citrate Ga-67 Fe-analogue Bronchogenous
More informationOptimized. clinical pathway. propels high utilization of PET/MR at Pitié-Salpêtrière Hospital
Optimized propels high utilization of PET/MR at Pitié-Salpêtrière Hospital clinical pathway As one of Europe s largest teaching hospitals, Pitié-Salpêtrière Hospital is renowned for its innovative research
More informationPET/CT Frequently Asked Questions
PET/CT Frequently Asked Questions General Q: Is FDG PET specific for cancer? A: No, it is a marker of metabolism. In general, any disease that causes increased metabolism can result in increased FDG uptake
More informationNuclear medicine methods in the urogenital system
Nuclear medicine methods in the urogenital system Anatomy of the kidneys I. Anatomy of the kidneys II. The types of examinations Static examinations (scintigraphy): 1) the radiopharmaceutical is administered
More information8/10/2016. PET/CT for Tumor Response. Staging and restaging Early treatment response evaluation Guiding biopsy
PET/CT for Tumor Response Evaluation August 4, 2016 Wei Lu, PhD Department of Medical Physics www.mskcc.org Department of Radiation Oncology www.umaryland.edu FDG PET/CT for Cancer Imaging Staging and
More informationLos Angeles Radiological Society 62 nd Annual Midwinter Radiology Conference January 31, 2010
Los Angeles Radiological Society 62 nd Annual Midwinter Radiology Conference January 31, 2010 Self Assessment Module on Nuclear Medicine and PET/CT Case Review FDG PET/CT IN LYMPHOMA AND MELANOMA Submitted
More informationBreast Cancer PET/CT Imaging Protocol
Breast Cancer PET/CT Imaging Protocol Scanning Protocol: Patients are scanned from the top of the neck through the pelvis. Arms-up position is used to avoid beam-hardening artifact in the chest and abdomen.
More informationPET IMAGING (POSITRON EMISSION TOMOGRAPY) FACT SHEET
Positron Emission Tomography (PET) When calling Anthem (1-800-533-1120) or using the Point of Care authorization system for a Health Service Review, the following clinical information may be needed to
More informationTypical PET Image. Elevated uptake of FDG (related to metabolism) Lung cancer example: But where exactly is it located?
Typical PET Image Elevated uptake of FDG (related to metabolism) Lung cancer example: But where exactly is it located? PET/CT Oncology Imaging Anatometabolic fusion images are useful in the management
More informationIntroduction Pediatric malignancies Changing trends & Radiation burden Radiation exposure from PET/CT Image gently PET & CT modification - PET/CT
Introduction Pediatric malignancies Changing trends & Radiation burden Radiation exposure from PET/CT Image gently PET & CT modification - PET/CT protocols Tips Leukaemia / lymphoma: ~ 35% acute lymphoblastic
More informationobjectives Pitfalls and Pearls in PET/CT imaging Kevin Robinson, DO Assistant Professor Department of Radiology Michigan State University
objectives Pitfalls and Pearls in PET/CT imaging Kevin Robinson, DO Assistant Professor Department of Radiology Michigan State University To determine the regions of physiologic activity To understand
More informationUnderstanding Biological Activity to Inform Drug Development
National Cancer Policy Forum Understanding Biological Activity to Inform Drug Development December 12, 2016 Wolfgang Weber Molecular Imaging and Therapy Service Department of Radiology RECIST Response
More informationLong-term Results of a Comparative PET/CT and PET/MRI Study of 11 C-Acetate and 18 F-Fluorocholine for Restaging of Early Recurrent Prostate Cancer
ORIGINAL ARTICLE Long-term Results of a Comparative PET/CT and PET/MRI Study of 11 C-Acetate and 18 F-Fluorocholine for Restaging of Early Recurrent Prostate Cancer Giorgio Lamanna, MD,* Claire Tabouret-Viaud,
More informationPositron Emission Tomography in Lung Cancer
May 19, 2003 Positron Emission Tomography in Lung Cancer Andrew Wang, HMS III Patient DD 53 y/o gentleman presented with worsening dyspnea on exertion for the past two months 30 pack-year smoking Hx and
More informationPET-MRI in malignant bone tumours. Lars Stegger Department of Nuclear Medicine University Hospital Münster, Germany
PET-MRI in malignant bone tumours Lars Stegger Department of Nuclear Medicine University Hospital Münster, Germany Content From PET to PET/MRI General considerations Bone metastases Primary bone tumours
More informationPET/MR. Are You Ready?? Derek Lee, BS, CNMT, PET
PET/MR Are You Ready?? Derek Lee, BS, CNMT, PET Allow Myself to Introduce Myself I ve been around a while: 23+ years in Nuclear Medicine and counting PET & PET/CT for 13 years and counting Currently working
More informationBone PET/MRI : Diagnostic yield in bone metastases and malignant primitive bone tumors
Bone PET/MRI : Diagnostic yield in bone metastases and malignant primitive bone tumors Lars Stegger, Benjamin Noto Department of Nuclear Medicine University Hospital Münster, Germany Content From PET to
More informationMaximizing the Utility of Integrated PET/MRI in Clinical Applications
Maximizing the Utility of Integrated PET/MRI in Clinical Applications Spencer Behr, MD Department of Nuclear Medicine & Abdominal Imaging University of California, San Francisco PET/MR at UCSF Device:
More informationPET/CT and PET/MR of Cardiac Tumors
PET/CT and PET/MR of Cardiac Tumors Andrew W. Bowman, MD PhD Assistant Professor of Radiology Mayo Clinic Florida NASCI Annual Meeting San Antonio, TX Oct 9, 2017 2017 MFMER slide-1 Disclosures No financial
More informationMolecular Imaging and Cancer
Molecular Imaging and Cancer Cancer causes one in every four deaths in the United States, second only to heart disease. According to the U.S. Department of Health and Human Services, more than 512,000
More informationRyan Niederkohr, M.D. Slides are not to be reproduced without permission of author
Ryan Niederkohr, M.D. CMS: PET/CT CPT CODES 78814 Limited Area (e.g., head/neck only; chest only) 78815 78816 Regional (skull base to mid-thighs) True Whole Body (skull vertex to feet) SELECTING FIELD
More informationClinical indications for positron emission tomography
Clinical indications for positron emission tomography Oncology applications Brain and spinal cord Parotid Suspected tumour recurrence when anatomical imaging is difficult or equivocal and management will
More informationUsing PET/CT in Prostate Cancer
Using PET/CT in Prostate Cancer Legal Disclaimer These materials were prepared in good faith by MITA as a service to the profession and are believed to be reliable based on current scientific literature.
More informationFieldStrength. Leuven research is finetuning. whole body staging
FieldStrength Publication for the Philips MRI Community Issue 40 May 2010 Leuven research is finetuning 3.0T DWIBS for whole body staging The University Hospital of Leuven is researching 3.0T whole body
More informationperformed to help sway the clinician in what the appropriate diagnosis is, which can substantially alter the treatment of management.
Hello, I am Maura Polansky at the University of Texas MD Anderson Cancer Center. I am a Physician Assistant in the Department of Gastrointestinal Medical Oncology and the Program Director for Physician
More informationWhat Radiologists do?
Multimodality Imaging in Oncology 2018 March 5 th 9th Diagnostic Imaging in Oncology What Radiologists do? Chikako Suzuki, MD, PhD Department of Diagnostic Radiology, KS Solna Department of Molecular Medicine
More informationPET/CT for Therapy Assessment in Oncology
PET/CT for Therapy Assessment in Oncology Rodolfo Núñez Miller, M.D. Nuclear Medicine Section Division of Human Health International Atomic Energy Agency Vienna, Austria Clinical Applications of PET/CT
More informationPrinciples of nuclear metabolic imaging. Prof. Dr. Alex Maes AZ Groeninge Kortrijk and KULeuven Belgium
Principles of nuclear metabolic imaging Prof. Dr. Alex Maes AZ Groeninge Kortrijk and KULeuven Belgium I. Molecular imaging probes A. Introduction - Chemical disturbances will precede anatomical abnormalities
More informationIndications of PET/CT in oncology
Monday, August 27, 2012 Session 1, 10:00-10:40 Indications of PET/CT in oncology Helle Westergren Hendel MD, PhD, assistant professor Bacelor in Leadership & Health Ecomomics Head of Clinical PET, Herlev
More informationOptimized PET/CT protocols: how much CT is needed? Increasing use of PET-CT. Imaging in Lymphoma
BVS/ABR Workshop 2011 on dose related to multimodality imaging Optimized PET/CT protocols: how much CT is needed? 2008 Mean medical radiation exposure/head Belgium= 2.42 msv The Netherlands= 0.8 msv Belgium
More informationNuclear Medicine: Basics to therapy
Nuclear Medicine: Basics to therapy RCP Medical careers day Dr Sabina Dizdarevic MD MSc PhD FRCP Dr Deena Neriman MBBS FRCR Ms Charlotte Weston CEO BNMS On behalf of the British Nuclear Medicine Society
More informationImaging of bone metastases
Imaging of bone metastases Antoine Feydy Service de Radiologie B Hôpital Cochin APHP Université Paris Descartes antoine.feydy@aphp.fr MEXICO 2016 INTRODUCTION Diagnostic Imaging Imaging Modalities Strengths,
More informationHybrid Imaging SPECT/CT PET/CT PET/MRI. SNMMI Southwest Chapter Aaron C. Jessop, MD
Hybrid Imaging SPECT/CT PET/CT PET/MRI SNMMI Southwest Chapter 2014 Aaron C. Jessop, MD Assistant Professor, Department of Nuclear Medicine UT MD Anderson Cancer Center, Houston, Texas Complimentary role
More informationDr Hugh Dixson Departments of Nuclear Medicine & Ultrasound and Gastroenterology Bankstown Hospital Sydney, Australia
Dr Hugh Dixson Departments of Nuclear Medicine & Ultrasound and Gastroenterology Bankstown Hospital Sydney, Australia Fee for service unregulated fees, mostly unlimited services Public hospitals Public
More informationPOSITRON EMISSION TOMOGRAPHY (PET)
Status Active Medical and Behavioral Health Policy Section: Radiology Policy Number: V-27 Effective Date: 08/27/2014 Blue Cross and Blue Shield of Minnesota medical policies do not imply that members should
More informationAn Introduction to PET Imaging in Oncology
January 2002 An Introduction to PET Imaging in Oncology Janet McLaren, Harvard Medical School Year III Basics of PET Principle of Physiologic Imaging: Allows in vivo visualization of structures by their
More informationJoint Comments on Positron Emission Tomography (NaF-18) to Identify Bone Metastasis of Cancer (CAG-00065R1)
July 2, 2009 Tamara Syrek Jensen, J.D. Acting Director, Coverage and Analysis Group Centers for Medicare & Medicaid Services 7500 Security Blvd., Mail Stop C1-09-06 Baltimore, MD 21244 Re: Joint Comments
More informationShort summary of published results of PET with fluoromethylcholine (18F) in prostate cancer
Short summary of published results of PET with fluoromethylcholine (18F) in prostate cancer JN TALBOT and all the team of Service de Médecine Nucléaire Hôpital Tenon et Université Pierre et Marie Curie,
More informationThe Drug Development Paradigm in Oncology: Role of Imaging Hedvig Hricak MSKCC
The Drug Development Paradigm in Oncology: Role of Imaging Hedvig Hricak MSKCC Precision Medicine: Imaging in Clinical Trials and Drug Development* Critical elements: Patient Selection, Dose Finding &
More informationIdentifying Image Artifacts, Their Causes and How to Fix Them: PET. Brad J Kemp, PhD Mayo Clinic, Rochester, MN
Identifying Image Artifacts, Their Causes and How to Fix Them: PET Brad J Kemp, PhD Mayo Clinic, Rochester, MN Case 1 Can we scan with a defective block detector? Daily Quality Assurance Results Singles
More informationPositron Emission Tomography (PET) for Staging Low-Grade Non-Hodgkin s Lymphomas (NHL)
CANCER BIOTHERAPY & RADIOPHARMACEUTICALS Volume 16, Number 4, 2001 Mary Ann Liebert, Inc. Positron Emission Tomography (PET) for Staging Low-Grade Non-Hodgkin s Lymphomas (NHL) F. Najjar, R. Hustinx, G.
More informationCLINICAL IMPLEMENTATION OF HYBRID IMAGING CLINICAL IMPLEMENTATION OF HYBRID IMAGING COMBINED IMAGING CLINICAL IMPLEMENTATION OF
HYBRID OBJECTIVES OF ADDING CT-SCANNING TO NM? CLINICAL IMPLEMENTATION OF François Jamar UCL, Brussels ABR-BVS Workshop, Antwerp, Feb. 18, 2011 HYBRID COMBINED COMBINED ( PET AND CT) In-WBC 111 In COMBINED
More informationZurich, January 19, 2018
Brain metastases as first presentation of malignancy: Immediate management, differential diagnosis; prevalence of primaries and suggested work-up Symposium on Brain Metastasis Cancer Center Zurich Zurich,
More informationSubject: PET Scan With or Without CT Attenuation. Original Effective Date: 11/7/2017. Policy Number: MCR: 610. Revision Date(s): Review Date:
Subject: PET Scan With or Without CT Attenuation Policy Number: MCR: 610 Revision Date(s): MHW Original Effective Date: 11/7/2017 Review Date: DISCLAIMER This Molina Clinical Review (MCR) is intended to
More informationRegional Training Course on PET/CT in Oncology. (RER-6.035) PROGRAM
Regional Training Course on PET/CT in Oncology. (RER-6.035) Riga and Liepaja (Latvia), October 3rd- 6th, 2016 Venue: Nuclear Medicine Centre, Gardenes Street 13, Riga, LATVIA (NOTE: Learning objectives
More informationMedical Policy An independent licensee of the Blue Cross Blue Shield Association
PET Scanning: Oncologic Applications Page 1 of 88 Medical Policy An independent licensee of the Blue Cross Blue Shield Association Title: Positron Emission Tomography (PET) Scanning: Oncologic Applications
More informationResearch Article Prevalence of Clinically Significant Extraosseous Findings on Unenhanced CT Portions of 18 F-Fluoride PET/CT Bone Scans
The Scientific World Journal Volume 2012, Article ID 979867, 5 pages doi:10.1100/2012/979867 The cientificworldjournal Research Article Prevalence of Clinically Significant Extraosseous Findings on Unenhanced
More informationPET Steering Committee Meeting Minutes. Wednesday, January 20 th, 2016 Time: 1:30-3:30pm
PET Steering Committee Meeting Minutes Wednesday, January 20 th, 2016 Time: 1:30-3:30pm Committee Members Present: U. Metser (Chair), R. dekemp, M. Freeman, M. Greenberg, D. Hussey, A. Singnurkar, Y. Ung
More information4D PET: promises and limitations
4D PET: promises and limitations Tinsu Pan, Ph.D. M.D. Anderson Cancer Center The University of Texas Background Outlines Gating techniques: Deep inspiration breath hold 4D PET/CT Non-gating techniques
More informationPage: 1 of 29. For this policy, PET scanning is discussed for the following 4 applications in oncology:
Emission Tomography Scanning Page: 1 of 29 Last Review Status/Date: June 2015 Description Positron emission tomography (PET) scans are based on the use of positron-emitting radionuclide tracers coupled
More informationWhole Body MRI. Dr. Nina Tunariu. Prostate Cancer recurrence, progression and restaging
Whole Body MRI Prostate Cancer recurrence, progression and restaging Dr. Nina Tunariu Consultant Radiology Drug Development Unit and Prostate Targeted Therapies Group 12-13 Janeiro 2018 Evolving Treatment
More informationThe Importance of PET/CT in Human Health. Homer A. Macapinlac, M.D.
The Importance of PET/CT in Human Health Homer A. Macapinlac, M.D. Learning objectives Provide an overview of the impact of PET/CT imaging on the management of patients and its impact on health care expenditures.
More informationCT Contrast Protocols for Different Organ Imaging
CT Contrast Protocols for Different Organ Imaging g Paul Shreve, M.D. Advanced Radiology Services, P.C. & Spectrum Health Grand Rapids, MI, USA Correlative Imaging Council Society of Nuclear Medicine 56
More informationEvaluation of Lung Cancer Response: Current Practice and Advances
Evaluation of Lung Cancer Response: Current Practice and Advances Jeremy J. Erasmus I have no financial relationships, arrangements or affiliations and this presentation will not include discussion of
More informationOncologic Applications of PET Scanning
6.01.26 Oncologic Applications of PET Scanning Section 6.0 Radiology Subsection Effective Date February 15, 2015 Original Policy Date January 26, 2009 Next Review Date December 2015 Description Positron
More informationThe Proper Use of PET/CT in Tumoring Imaging
The Proper Use of PET/CT in Tumoring Imaging Mijin Yun, M.D. Jong Doo Lee, M.D. Department of Radiology / Division of Nuclear Medicine Yonsei University College of Medicine, Severance Hospital E mail :
More informationPSMA PET SCANNING AND THERANOSTICS IN PROSTATE CANCER KEVIN TRACEY, MD, FRCPC PRECISION DIAGNSOTIC IMAGING REGIONAL PET/CT CENTRE
PSMA PET SCANNING AND THERANOSTICS IN PROSTATE CANCER KEVIN TRACEY, MD, FRCPC PRECISION DIAGNSOTIC IMAGING REGIONAL PET/CT CENTRE DISCLOSURES/CONFLICTS NONE OBJECTIVES Understand current diagnostic role
More informationF NaF PET/CT in the Evaluation of Skeletal Malignancy
F NaF PET/CT in the Evaluation of Skeletal Malignancy Andrei Iagaru, MD September 26, 2013 School of of Medicine Ø Introduction Ø F NaF PET/CT in Primary Bone Cancers Ø F NaF PET/CT in Bone Metastases
More informationCancer Prevention & Control in Adolescent & Young Adult Survivors
+ Cancer Prevention & Control in Adolescent & Young Adult Survivors NCPF Workshop July 15-16, 2013 Patricia A. Ganz, MD UCLA Schools of Medicine & Public Health Jonsson Comprehensive Cancer Center + Overview
More information2004 SNM Mid-Winter Educational Symposium
1 2 20 Numeric values 15 10 5 0 SUV corr hs 18FDG Slope corr hs SUV corr hs Slope corr hs 11C-methionin 3 11C-methionine Grading and delineation of brain tumors Differentiation of malignant from benign
More information8/3/2016. Consultant for / research support from: Astellas Bayer Bracco GE Healthcare Guerbet Medrad Siemens Healthcare. Single Energy.
U. Joseph Schoepf, MD Prof. (h.c.), FAHA, FSCBT-MR, FNASCI, FSCCT Professor of Radiology, Medicine, and Pediatrics Director, Division of Cardiovascular Imaging Consultant for / research support from: Astellas
More informationDepartment of Nuclear Medicine with Positron Emission Tomography
(PET) Unit [1] Contact information: Registration: +48 41 367 4850 Main office: +48 41 367 4860 Fax: +48 41 367 4887 e-mail: zmnsco@onkol.kielce.pl [2] Head of the Department: Professor Janusz Braziewicz
More informationContents. 3 Pneumology Introduction Positron Emission Tomography: Past and Present 1. 2 Fundamentals. xxx
xxx IX Contents 1 Introduction Positron Emission Tomography: Past and Present 1 1.1 Survey.......................... 1 Physical and Biochemical Fundamentals.... 2 PET in National and International Medical
More information8/10/2016. PET/CT Radiomics for Tumor. Anatomic Tumor Response Assessment in CT or MRI. Metabolic Tumor Response Assessment in FDG-PET
PET/CT Radiomics for Tumor Response Evaluation August 1, 2016 Wei Lu, PhD Department of Medical Physics www.mskcc.org Department of Radiation Oncology www.umaryland.edu Anatomic Tumor Response Assessment
More informationDr Sneha Shah Tata Memorial Hospital, Mumbai.
Dr Sneha Shah Tata Memorial Hospital, Mumbai. Topics covered Lymphomas including Burkitts Pediatric solid tumors (non CNS) Musculoskeletal Ewings & osteosarcoma. Neuroblastomas Nasopharyngeal carcinomas
More information14/09/2013 FDG PET PET-CT = FDG PET-CT. = Metabolism. Anatometabolic Imaging. = Anatomy. Nuclear Medicine in the Era of Hybrid Imaging
Nuclear Medicine in the Era of Hybrid Imaging Focus on a New SPECT-CT Device : HWK-4 Tarik Belhocine, MD, Ph.D Nuclear Medicine = SPECT = Functional Imaging Function Radiology = Morphological Imaging Anatomy
More informationActualités TEP-IRM en Oncologie: Apprendre de TEP-TD comment faire
Actualités TEP-IRM en Oncologie: Apprendre de TEP-TD comment faire JFMN 15, La Rochelle, May 29, 2015 Gustav K. von Schulthess, MD, PhD, MD hon Dept. Medical Radiology, Nuclear Medicine Univ. Hospital
More informationInternational Atomic Energy Agency Department of Technical Cooperation And Nuclear Medicine and Diagnostic Imaging Section Division of Human Health
International Atomic Energy Agency Department of Technical Cooperation And Nuclear Medicine and Diagnostic Imaging Section Division of Human Health RAS6074 RAS6074 Improving Quality of Life of Cancer Patients
More informationNew imaging techniques: let there be light. Felix M. Mottaghy Department of Nuclear Medicine University Hospital KU Leuven
New imaging techniques: let there be light Felix M. Mottaghy Department of Nuclear Medicine University Hospital KU Leuven Medical imaging and the pathology cascade Molecular/Cellular disturbance Alterations
More informationCancers of unknown primary : Knowing the unknown. Prof. Ahmed Hossain Professor of Medicine SSMC
Cancers of unknown primary : Knowing the unknown Prof. Ahmed Hossain Professor of Medicine SSMC Definition Cancers of unknown primary site (CUPs) Represent a heterogeneous group of metastatic tumours,
More informationThe Use of PET Scanning in Urologic Oncology
The Use of PET Scanning in Urologic Oncology Dr Nicholas C. Buchan Uro-oncology Fellow 1 2 Aims To understand the basic concepts underlying PET scanning. Understand the emerging role of PET Scanning for
More informationTesticular relapse of non-hodgkin Lymphoma noted on FDG-PET
Testicular relapse of non-hodgkin Lymphoma noted on FDG-PET Stephen D. Scotti 1*, Jennifer Laudadio 2 1. Department of Radiology, North Carolina Baptist Hospital, Winston-Salem, NC, USA 2. Department of
More informationMEASUREMENT OF EFFECT SOLID TUMOR EXAMPLES
MEASUREMENT OF EFFECT SOLID TUMOR EXAMPLES Although response is not the primary endpoint of this trial, subjects with measurable disease will be assessed by standard criteria. For the purposes of this
More informationPET/CT in breast cancer staging
PET/CT in breast cancer staging Anni Morsing Consultant, PhD, DMSc Rigshospitalet 1 18F- FDG PET/CT for breastcancer staging Where is the clinical impact? To which women should 18F- FDG PET/CT be offered?
More informationMedical Policy An independent licensee of the Blue Cross Blue Shield Association
PET Scanning: Oncologic Applications Page 1 of 42 Medical Policy An independent licensee of the Blue Cross Blue Shield Association Title: See also: Positron Emission Tomography (PET) Scanning: Oncologic
More informationRadionuclide detection of sentinel lymph node
Radionuclide detection of sentinel lymph node Sophia I. Koukouraki Assoc. Professor Department of Nuclear Medicine Medicine School, University of Crete 1 BACKGROUND The prognosis of malignant disease is
More information2017 SNMMI Mid-Winter and ACNM Annual Meeting Arizona Grand Resort Phoenix, AZ
Grand Ballroom FI 7:30-10:00 am Thursday, January 19, 2017 Sierra Ballroom Welcome and Introductions from CSNM/SNMMI/ACNM Non-Nuclear Molecular Imaging, MR and Optical ACNM Oral Research Presentations
More informationEmerging Referral Patterns for Whole-Body Diffusion Weighted Imaging (WB-DWI) in an Oncology Center
Emerging Referral Patterns for Whole-Body Diffusion Weighted Imaging (WB-DWI) in an Oncology Center Poster No.: C-1296 Congress: ECR 2014 Type: Scientific Exhibit Authors: G. Petralia 1, G. Conte 1, S.
More informationRadionuclides in Medical Imaging. Danielle Wilson
Radionuclides in Medical Imaging Danielle Wilson Outline Definitions History and development Radionuclide applications & techniques in imaging Conclusion Definition #1 : Radionuclide An unstable nucleus
More informationTechnological leapfrogging at a hospital near you What s going on and why it matters?
Technological leapfrogging at a hospital near you What s going on and why it matters? Antonis Kalemis, PhD MBA Philips - Advanced Molecular Imaging Snr Manager, Clinical Science AIPES (European Association
More informationROLE OF PET-CT IN BREAST CANCER, GUIDELINES AND BEYOND. Prof Jamshed B. Bomanji Institute of Nuclear Medicine UCL Hospitals London
ROLE OF PET-CT IN BREAST CANCER, GUIDELINES AND BEYOND Prof Jamshed B. Bomanji Institute of Nuclear Medicine UCL Hospitals London CANCER Key facts Estimated 15.2 million new cases per year in 2015 worldwide
More informationNuclear Medicine in the Diabetic Foot
26.11.2015, Uniklinik Balgrist Nuclear Medicine in the Diabetic Foot Martin Hüllner Nuklearmedizin und Neuroradiologie, USZ / UZH Outline A. Imaging modalities brief technical overview B. Nuclear medicine
More informationUtility of Positron Emission Tomography (PET)
11 : 1 Utility of Positron Emission Tomography (PET) in Medicine Summery The PET imaging is the recent advance in Nuclear Medicine which gives information at the molecular level. This helps in diagnosing,
More informationOriginal Policy Date
MP 6.01.17 Oncologic Applications of PET Scanning Medical Policy Section Radiology Issue 12:2013 Original Policy Date 12:2013 Last Review Status/Date Reviewed with literature/12:2013 Return to Medical
More informationNew Visions in PET: Surgical Decision Making and PET/CT
New Visions in PET: Surgical Decision Making and PET/CT Stanley J. Goldsmith, MD Director, Nuclear Medicine Professor, Radiology & Medicine New York Presbyterian Hospital- Weill Cornell Medical Center
More informationGa68 Imaging. Roland HUSTINX Division of Nuclear Medicine and Oncologic Imaging Centre Hospitalier Universitaire de Liège Belgium
Ga68 Imaging Roland HUSTINX Division of Nuclear Medicine and Oncologic Imaging Centre Hospitalier Universitaire de Liège Belgium 68 Ga Produced by a 68 Ge/ 68 Ga generator Decays by positron emission
More informationUpdate in Nuclear Imaging of Amyloidosis and Sarcoidosis
Update in Nuclear Imaging of Amyloidosis and Sarcoidosis Balaji Tamarappoo MD, PhD, Cedars-Sinai Heart Institute and Biomedical Imaging Research Institute Cedars-Sinai Medical Center Los Angeles, CA, USA.
More information2005 American College of Radiology /05/$30.00 DOI /j.jacr a Duke University Medical Center, Durham, North Carolina.
Concurrent PET/CT with an Integrated Imaging System: Intersociety Dialogue from the Joint Working Group of the American College of Radiology, the Society of Nuclear Medicine, and the Society of Computed
More informationThe Role of PET / CT in Lung Cancer Staging
July 2004 The Role of PET / CT in Lung Cancer Staging Vlad Vinarsky, Harvard Medical School Year IV Patient AM HPI: 81 yo F p/w hemoptysis x 1 month LLL lesion on CXR, not responsive to Abx 35 pack-year
More informationPET/CT in oncology. Positron emission tomography
Clinical Medicine 2012, Vol 12, No 4: 368 72 PET/CT in oncology Fahim-Ul-Hassan, SpR Nuclear Medicine, Guy s Hospital, London; Gary J Cook, professor of Clinical PET, KCL Division of Imaging Sciences &
More informationHEALTHFIRST 2011 RADIOLOGY PROGRAM CODE LIST
HEALTHFIRST 2011 RADIOLOGY PROGRAM CODE LIST Outpatient Radiology utilization call Carecore at 1-877-773-6964 Modality CPT CODE Description CT SCANS 70450 CT HEAD/BRAIN W/O CONTRAST CT SCANS 70460 CT HEAD/BRAIN
More informationThe role of appropriateness criteria in the planning of health services: the case of FDG-PET in oncology
V Annual Meeting of Health Tecnology Assessment International (HTAi) MONTREAL 8 july 2008 The role of appropriateness criteria in the planning of health services: the case of FDG-PET in oncology L. BALLINI
More informationChapter 10. Summary, conclusions and future perspectives
Chapter 10 Summary, conclusions and future perspectives 10.1 SUMMARY In this thesis, a new tumor imaging tracer in nuclear medicine is studied. This 123 tracer, L-3-[ I]Iodo-alpha-methyl-tyrosine (IMT),
More information